| Document Date: 2015-02-19 09:17:00
Open Document File Size: 536,16 KBShare Result on Facebook
Company Urology Branch Pharma / / / Facility University Medical Center Freiburg Dept. / Freiburg University / University Hospital Freiburg / / / IndustryTerm microPET imaging / excellent tools / imaging / prostate cancer imaging / final imaging / Therapy of Prostate Cancer / / MedicalCondition frequent malignant disease / PSMA-negative tumors / tumor / DU145 tumor / common cancer / tumors / PSMA expressing prostate cancer / prostate cancers / solid tumors / PSMA positive tumors / prostate cancer Market Potential Prostate cancer / high tumor / PSMA-positive tumors / Prostate Cancer Technology The Prostate Specific Membrane antigen / human prostate cancer / PSMA expressing tumors / SCID / Germany Results Prostate cancer / prostate cancer / / MedicalTreatment radioimmunotherapy / / Organization Freiburg University / U. Wetterauer Department of Urology / African Union / Freiburg University Medical Center / / Person Philipp Wolf / / / Position Innovation Responsible Scientist / / Technology Antibodies / Freiburg University Medical Center Dr. Claudia Skamel Campus Technologies / /
SocialTag |
Anti-PSMA Antibodies Novel Agents for Diagnosis and Therapy of Prostate Cancer Technology The Prostate Specific Membrane antigen (PSMA) is highly expressed by virtually all prostate cancers and is currently the focus of